Conferences - Results from #12000

WCE 2011 - Flexible ureteroscopy for renal stones >1cm - the method of choice? - Session Highlights February 10, 2012

WCE 2011 - Human versus robot: Who can perform more accurate prostate biopsy? - Session Highlights February 10, 2012

WCE 2011 - Anatomical variation between the prone, supine and supine oblique positions on computed tomography: Implications for percutaneous nephrolithotomy access - Session Highlights February 10, 2012

WCE 2011 - High fidelity team-based simulation training: Laparoscopic renal vein injury scenario - Session Highlights February 10, 2012

WCE 2011 - Portable simulators training enhances the laparoscopic skills acquisition: Randomised controlled trial - Session Highlights February 10, 2012

WCE 2011 - Prospective evaluation of patient satisfaction with treatment outcomes after shock wave lithotripsy and ureteroscopy for ureteral stones - Session Highlights February 10, 2012

WCE 2011 - Prospective evaluation of routine fluorescence cystoscopy demonstrates significantly increased CIS detection - Session Highlights February 10, 2012

WCE 2011 - The CROES Percutaneous Nephrolithotomy Global Study: Urinary tract infections and post-operative fever in percutaneous nephrolithotomy - Session Highlights February 10, 2012

WCE 2011 - What should we measure? Predicting outcomes with flexible ureteroscopy for large renal stones - Session Highlights February 10, 2012

GU Cancers Symposium 2012 - mCRPC opportunities for the urologist and radiation oncologist: An interview with Adam M. Kibel, Chairman, GU Cancers Symposium - Session Highlights February 8, 2012

GU Cancers Symposium 2012 - Prostate cancer: Take home message - Session Highlights February 8, 2012

GU Cancers Symposium 2012 - Radium-223 chloride impact on skeletal-related events in patients with castration-resistant prostate cancer (CRPC) with bone metastases: A phase III randomized trial (ALSYMPCA) - Session Highlights February 8, 2012

GU Cancers Symposium 2012 - Empiric antibiotics for an elevated PSA: A randomized, prospective multiinstitutional trial - Session Highlights February 7, 2012

GU Cancers Symposium 2012 - Validation of a cell-cycle progression (CCP) gene panel to improve risk stratification in a contemporary prostatectomy cohort - Session Highlights February 6, 2012

GU Cancers Symposium 2012 - A phase 1 clinical trial of intravesical antisense oligonucleotide targeting heat shock protein (OGX-427) for the treatment of superficial bladder cancer - Session Highlights February 6, 2012

GU Cancers Symposium 2012 - A phase I clinical trial of intravesical antisense oligonucleotide targeting heat shock protein 27 (OGX-427) for the treatment of superficial bladder cancer - Poster February 6, 2012

GU Cancers Symposium 2012 - A randomized phase II study of OGX-427 + prednisone vs. prednisone alone in patients with chemotherapy-naïve metastatic castration resistant prostate cancer - Session Highlights February 6, 2012

GU Cancers Symposium 2012 - Hypofractionation for prostate cancer: Is less better? - Session Highlights February 3, 2012

GU Cancers Symposium 2012 - Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort - Poster February 3, 2012

GU Cancers Symposium 2012 - A Randomized phase II study of OGX-427 + prednisone vs. prednisone alone in patients with chemotherapy-naive metastatic castration resistant prostate cancer - Poster February 3, 2012

Page 601 of 616